Early research (Phase 1)Ended earlyNCT06334783What this trial is testingTIL for Patients With Advanced Solid TumorWho this might be right forAdvanced Solid Tumor Hervor Therapeutics 5
Testing effectiveness (Phase 2)Ended earlyNCT04203641What this trial is testingL-DOS47 Plus Doxorubicin in Advanced Pancreatic CancerWho this might be right forPancreas Cancer Helix BioPharma Corporation 28
Large-scale testing (Phase 3)Looking for participantsNCT04996017What this trial is testingAtezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)Who this might be right forMesotheliomas Pleural Gruppo Oncologico Italiano di Ricerca Clinica 162
Testing effectiveness (Phase 2)Study completedNCT03019640What this trial is testingUmbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's LymphomaWho this might be right forMantle Cell LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent Follicular Lymphoma+4 more M.D. Anderson Cancer Center 22
Not applicableWithdrawnNCT05584540What this trial is testingUNTIRE: Cancer-related Fatigue With Digital TreatmentWho this might be right forColorectal CancerFatigue Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Active Not RecruitingNCT02846623What this trial is testingAtezolizumab, Obinutuzumab, and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Relapsed or Refractory Richter SyndromeWho this might be right forChronic Lymphocytic LeukemiaRecurrent Transformed Chronic Lymphocytic LeukemiaRefractory Transformed Chronic Lymphocytic Leukemia+2 more M.D. Anderson Cancer Center 50
Not applicableNot Yet RecruitingNCT07368023What this trial is testingA Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Unresectable Hepatocellular CarcinomaWho this might be right forHepatocellular CarcinomaHepatocellular Carcinoma Non-resectable Ningbo Medical Center Lihuili Hospital 300
Testing effectiveness (Phase 2)Study completedNCT00376961What this trial is testingS0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell LymphomaWho this might be right forLymphoma SWOG Cancer Research Network 68
Post-approval studies (Phase 4)Study completedNCT02081469What this trial is testingProphylaxis of CHB Patients With Malignant Tumor Receiving ChemotherapyWho this might be right forHepatitis B, ChronicTumor Chang Gung Memorial Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00003124What this trial is testingHormone Therapy Plus Radiation Therapy in Treating Patients With Prostate CancerWho this might be right forProstate Cancer Herbert Irving Comprehensive Cancer Center 105
Testing effectiveness (Phase 2)Study completedNCT00006359What this trial is testingAndrogen Suppression Plus Radiation Therapy in Treating Patients With Prostate CancerWho this might be right forProstate Cancer Alliance for Clinical Trials in Oncology 63
Testing effectiveness (Phase 2)Study completedNCT02301988What this trial is testingIpatasertib (GDC-0068) in Combination With Paclitaxel as Neoadjuvant Treatment for Participants With Early Stage Triple Negative Breast CancerWho this might be right forBreast Cancer Genentech, Inc. 151
Post-approval studies (Phase 4)Not Yet RecruitingNCT07302841What this trial is testingTunlametinib + AG + Cetuximab β as First-Line Therapy for Advanced Pancreatic CancerWho this might be right forPancreatic Cancer Non-resectable Tianjin Medical University Cancer Institute and Hospital 28
Not applicableStudy completedNCT02446834What this trial is testingResearch of Intensive Lifestyle Intervention for PCOS Patients With IGTWho this might be right forPolycystic Ovary Syndrome RenJi Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00047021What this trial is testingCombination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or LymphomaWho this might be right forLeukemiaLymphoma Case Comprehensive Cancer Center 3
Testing effectiveness (Phase 2)Ended earlyNCT04552704What this trial is testingCD24Fc for the Treatment of Immune Related Adverse Events in Patients With Advanced Solid Tumors, TIRAEC StudyWho this might be right forAdvanced Malignant Solid Neoplasm Tianhong Li 3
Early research (Phase 1)Ended earlyNCT05038644What this trial is testingXmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic LeukemiaWho this might be right forAcute Myeloid LeukemiaT Cell Acute Lymphoblastic LeukemiaT Cell Lymphoblastic Lymphoma Ehab L Atallah 22
Large-scale testing (Phase 3)Looking for participantsNCT06765109What this trial is testingNeladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLCWho this might be right forNon-small Cell Lung CancerAnaplastic Lymphoma Kinase-positive Nuvalent Inc. 450
Not applicableUnknownNCT05409352What this trial is testingSelf-administered Acupressure to Improve Cancer-related Fatigue Among Cancer Patients Undergoing ChemotherapyWho this might be right forCancer, BreastFatigueAcupressure+1 more The University of Hong Kong 138
Not applicableLooking for participantsNCT06876532What this trial is testingEvaluation of the Inflammation-based Index as a Predictive Marker of Clinical and Radiological Response in Patients Treated With Lu-177 Oxodotreotide for Intestinal Neuroendocrine TumourWho this might be right forIntestinal Neuroendocrine Tumor Institut Claudius Regaud 150